A detailed history of Ifp Advisors, Inc transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Ifp Advisors, Inc holds 325 shares of RDY stock, worth $4,540. This represents 0.0% of its overall portfolio holdings.

Number of Shares
325
Previous 54 501.85%
Holding current value
$4,540
Previous $4,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 04, 2025

BUY
$13.99 - $79.75 $3,791 - $21,612
271 Added 501.85%
325 $5,000
Q2 2024

Jul 30, 2024

BUY
$68.26 - $76.19 $2,116 - $2,361
31 Added 134.78%
54 $4,000
Q1 2024

Jul 30, 2024

BUY
$67.36 - $77.59 $1,549 - $1,784
23 New
23 $1,000
Q3 2022

Nov 08, 2022

BUY
$49.9 - $57.32 $4,391 - $5,044
88 New
88 $18,000
Q3 2021

Oct 06, 2021

SELL
$60.19 - $75.29 $0 - $0
0 Closed
0 $0
Q2 2021

Jul 13, 2021

BUY
$62.12 - $74.2 $0 - $0
0 New
0 $0
Q1 2021

Apr 30, 2021

BUY
$57.98 - $73.08 $0 - $0
0 New
0 $0
Q4 2020

Jan 25, 2021

BUY
$62.61 - $71.29 $0 - $0
0 New
0 $0
Q3 2020

Oct 29, 2020

BUY
$51.39 - $72.41 $0 - $0
0 New
0 $0
Q2 2020

Aug 05, 2020

BUY
$39.55 - $54.65 $0 - $0
0 New
0 $0
Q1 2020

May 12, 2020

BUY
$34.75 - $45.85 $0 - $0
0 New
0 $0
Q4 2019

Jan 17, 2020

BUY
$36.66 - $41.78 $0 - $0
0 New
0 $0
Q3 2019

Nov 07, 2019

BUY
$34.82 - $39.26 $0 - $0
0 New
0 $0
Q1 2019

May 15, 2019

SELL
$35.77 - $40.57 $4,507 - $5,111
-126 Closed
0 $0
Q4 2018

Jan 23, 2019

SELL
$31.89 - $38.44 $701 - $845
-22 Reduced 14.86%
126 $4,000
Q2 2018

Aug 07, 2018

SELL
$28.49 - $35.06 $15,498 - $19,072
-544 Reduced 78.61%
148 $0
Q1 2018

Jun 03, 2019

BUY
$31.93 - $39.54 $2,937 - $3,637
92 Added 15.33%
692 $26,000
Q1 2018

May 09, 2018

SELL
$31.93 - $39.54 $2,937 - $3,637
-92 Reduced 13.29%
600 $0
Q4 2017

Jan 24, 2018

BUY
$34.15 - $37.62 $3,141 - $3,461
92 Added 15.33%
692 $0
Q1 2017

Jun 03, 2019

SELL
N/A
-148 Reduced 19.79%
600 $24,000
Q4 2016

Jun 03, 2019

BUY
N/A
748
748 $34,000

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.32B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Ifp Advisors, Inc Portfolio

Follow Ifp Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.